ProShares UltraShort NASDAQ Biotechnology
6 hedge funds and large institutions have $550K invested in ProShares UltraShort NASDAQ Biotechnology in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
2
Closed
1
Calls
$4K
Puts
$23K
Net Calls
-$19K
Net Calls Change
+$4K
Top Buyers
1 |
1
IMC Chicago
Chicago,
Illinois
|
$271K |
2 |
2
UBS Group
Zurich,
Switzerland
|
$4.93K |
3 |
3
Morgan Stanley
New York
|
$5.85K |
Top Sellers
1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$0 |
2 |
2
Citadel Advisors
Miami,
Florida
|
$181K |
3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$85.3K |